CorFlow Therapeutics AG Company

CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complication rates in these patients.

Investors

Industry: Medical Technology
Headquarters: Zug
Estimated Revenue: Less than $1M

Visit Website
Register and Claim Ownership